By

The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved...

By

The series of compounds known as the halogenated phenazines, or HPs, can kill dangerous bacterial biofilms present in recurring and chronic bacterial infections such as methicillin-resistant Staphylococcus...

By

National Video Supply located in Santa Clarita, California is voluntarily recalling the following product to the consumer level: RHINO 7 3000 Platinum Capsules packaged in single 1 count blister hang tab...

By

Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma...

By

The U.S. Food and Drug Administration Tuesday approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph nodes. “Melanoma...

By

The U.S. Food and Drug Administration Friday granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations...

By

Cempra, Inc. announced recently that the U.S. Food and Drug Administration (FDA) has granted a qualified infectious disease product (QIDP) designation to Cempra’s investigational antibiotic product...

When chemical testing proves that most of the top-rated products for a popular supplement barely contain the supplement itself, it’s easy to be concerned. This is the current quality control issue...

By

The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer responding...

By

The U.S. Food and Drug Administration today announced it has awarded 18 new research grants totaling more than $19 million to boost the development of products for patients with rare diseases, which affect...